Ralph Brandenberger
Technik-/Wissenschafts-/F&E-Leiter bei NKARTA, INC.
Vermögen: 545 409 $ am 30.04.2024
Aktive Positionen von Ralph Brandenberger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NKARTA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | - |
Corporate Officer/Principal | 01.04.2018 | 01.01.2020 |
Karriereverlauf von Ralph Brandenberger
Ehemalige bekannte Positionen von Ralph Brandenberger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.05.2016 | 01.03.2018 |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Corporate Officer/Principal | 01.11.2012 | 01.04.2016 |
GERON CORPORATION | Corporate Officer/Principal | 01.08.2001 | 01.06.2012 |
Ausbildung von Ralph Brandenberger
University of Basel | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GERON CORPORATION | Health Technology |
NKARTA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Health Technology |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Health Technology |
- Börse
- Insiders
- Ralph Brandenberger
- Erfahrung